Abstract
Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Current Respiratory Medicine Reviews
Title:Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Volume: 12 Issue: 1
Author(s): Arthur L. Frank
Affiliation:
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Abstract: Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Export Options
About this article
Cite this article as:
Frank L. Arthur, Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151026222515
DOI https://dx.doi.org/10.2174/1573398X11666151026222515 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Purine Derivatives as Scaffolds for a Diversity of Biological Activities
Current Organic Chemistry Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges
Current Radiopharmaceuticals Developing Antitumor Magnetic Hyperthermia: Principles, Materials and Devices
Recent Patents on Anti-Cancer Drug Discovery The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry Integrin-Mediated Drug Resistance
Current Signal Transduction Therapy Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases
Current Drug Safety Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer
Current Cancer Drug Targets Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Current Pharmaceutical Design An Overview of the Design, Development and Applications of Biodegradable Stents
Drug Delivery Letters Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Current Drug Targets The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema
Current Molecular Medicine Jaridonin, a Novel Ent-Kaurene Diterpenoid from Isodon rubescens, Inducing Apoptosis via Production of Reactive Oxygen Species in Esophageal Cancer Cells
Current Cancer Drug Targets Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry <i>Zanthoxylum bungeanum</i> Seed Oil Elicits Autophagy and Apoptosis in Human Laryngeal Tumor Cells via PI3K/AKT/mTOR Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
Current Drug Therapy Evolution of Bronchoscopy
Current Respiratory Medicine Reviews